Rituximab-induced Acute Thrombocytopenia in a Patient with Follicular Lymphoma: A Case Report and Review of the Literature
Open Access
- 1 January 2018
- journal article
- review article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (8) , 1151-1154
Abstract
Rituximab is a highly effective agent that is used in the treatment of B-cell lymphoma. Rituximab-induced acute thrombocytopenia is a rare side effect that has previously been reported in a small number of patients with malignant lymphoma; its mechanism is still unknown. We herein report the case of a 74-year old man who was diagnosed with follicular lymphoma and who developed severe acute thrombocytopenia the day after the administration of rituximab. Coagulation abnormality, which mimicked disseminated intravascular coagulation, also appeared. When physicians use rituximab to treat high-risk patients, the platelet count should be closely monitored to avoid possible adverse events.Keywords
This publication has 21 references indexed in Scilit:
- Anti-CD20 antibody treatment of non-Hodgkin lymphomasClinical Immunology, 2016
- Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular LymphomaInternal Medicine, 2016
- The platelet Fc receptor, FcγRIIaImmunological Reviews, 2015
- Rituximab-Induced Acute Severe Thrombocytopenia: A Case Series in Patients With Mantle Cell LymphomaClinical Lymphoma Myeloma and Leukemia, 2013
- Rituximab-induced acute thrombocytopenia: an underappreciated entityLeukemia & Lymphoma, 2013
- Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of LiteratureCancer Investigation, 2008
- Severe hematological side effects following Rituximab therapy in children.2006
- Rituximab-induced acute thrombocytopenia: a report of two cases.2005
- Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceBlood, 2003
- Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasionLeukemia, 2001